# e+ OncoLogics Louisiana, LLC – FDA Inspection, Jul 9, 2024

Source: https://www.keypedia.com/records/fda_inspections/e-oncologics-louisiana-llc/8c5ba84c-740c-47d1-b0bc-813b41d85a52
Source feed: FDA_Inspections

> FDA inspection 1245125 of e+ OncoLogics Louisiana, LLC, July 09, 2024. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1245125
- Company Name: e+ OncoLogics Louisiana, LLC
- Inspection Date: 2024-07-09
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1171284 - 2022-03-28
- FDA Inspection 1046033 - 2018-01-18
- FDA Inspection 977278 - 2016-07-21
- FDA Inspection 907097 - 2014-12-15
- FDA Inspection 833821 - 2013-05-31

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/annette-melendez/bc1a065d-6408-4c4b-9dcf-c6884e8a75c4)

Company: https://www.keypedia.com/companies/e-oncologics-louisiana-llc/039f426a-8dbf-437e-aab0-a182d41dc4b5

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d